Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 20, 2024

Adjuvant Endocrine Therapy Choices in Premenopausal Patients With HR-Positive Early Breast Cancer

The Breast

 

Additional Info

The Breast
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
Breast 2024 Jul 09;77(xx)103769, L Arecco, MM Latocca, E Blondeaux, F Riccardi, C Mocerino, V Guarneri, E Mioranza, G Bisagni, E Gasparini, F Puglisi, A Membrino, A Ferro, V Adamo, F Giovanardi, S Tamberi, S Donati, E Landucci, L Biganzoli, S Piccinini, S Pastorino, E de Azambuja, F Poggio, M Lambertini, L Del Mastro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading